Collplant Biotechnologies Ltd (CLGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $14.27M
Last updated: Nov 13, 2026 at 4:00 PM ET
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 20.1% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 61.5, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about CLGN
News
CLGN Valuation
GNG's valuation label for CLGN is Fairly valued. It trades at 80.0x forward earnings.
- Forward P/E
- 80.0x
- P/FCF
- -0.6x
- P/B
- 2.3x
CLGN Profitability: Margins, ROIC and FCF
Collplant Biotechnologies (CLGN) has a gross margin of -521.7%, an operating margin of -3901.0% and a net margin of 0.0%. It posts a -3679.6% FCF margin.
- Gross margin
- -521.7%
- Operating margin
- -3901.0%
- Net margin
- 0.0%
- ROE
- -162.0%
- FCF margin
- -3679.6%
- FCF yield
- -174.8%
Collplant Biotechnologies Competitors
The companies most similar to Collplant Biotechnologies (CLGN) include Pluri, Celularity and Biocardia.
Sector: Healthcare
Companies most similar to Collplant BiotechnologiesCLGN Bull Case vs Bear Case
Bear case
- CLGN beat EPS estimates in 12.5% of its last 8 reported quarters.
- CLGN's quarterly revenue changed -39.7% year over year.
CLGN Earnings: Beat Rate
Collplant Biotechnologies (CLGN) beat the EPS estimate in 1 of the last 8 quarters (12.5%). Its next report is expected on Nov 24, 2026.
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -101.5%
CLGN Earnings Date
CLGN reports Nov 24, 2026. The date is estimated.
CLGN Earnings Call
The latest CLGN earnings call transcript on file is labeled 2024Q3.
Read the 2024Q3 transcriptUpdated Oct 7, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About CLGN
When does CLGN report earnings?
Collplant Biotechnologies Ltd (CLGN) is expected to report earnings on Nov 24, 2026.
Does CLGN pay dividends?
Collplant Biotechnologies Ltd (CLGN) does not currently pay a regular dividend.
What is CLGN's market cap?
Collplant Biotechnologies Ltd (CLGN) has a market capitalization of $14.27M with a current stock price of $4.64.
CLGN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.